Fierce Biotech News & Reports
WEB3 days ago · The Fierce 50 of 2024. Shining a spotlight on the people and companies who are driving meaningful change in healthcare, pharma and biotech. Ayla Ellison Sep 9, 2024 5:00am. Medtech News.
MedTech | Fierce Biotech
WEB4 days ago · The agency's researchers will conduct experiments to measure the amounts of metals that may leech out of tampons and enter the body under normal use. Conor Hale Sep 11, 2024 10:00am. Connect. The ...
Biotech | Fierce Biotech
WEBAug 20, 2024 · Shortly after a positive data drop for Eli Lilly’s efsitora, the Indianapolis-based company is again padding the case for its weekly insulin prospect. Fraiser Kansteiner Sep 11, 2024 2:05pm ...
Pharma - Fierce Biotech
WEB3 days ago · Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials. James Waldron Sep 11, 2024 11:45am. Connect.
New AI drug discovery powerhouse Xaira rises with $1B in funding
WEBApr 24, 2024 · The company emerged Tuesday with $1 billion in committed funding—that’s billion with a B—incubated by Arch Venture Partners and Foresite Labs with none other than Marc Tessier-Lavigne, Ph.D ...
The top biotech hubs in 2022 - Fierce Biotech
WEBBy Annalee Armstrong Jul 5, 2022 12:00am. startups real estate venture capital (VC) small biotechs. Top cities for biotechs include Boston, San Francisco, San Diego and a little corner of North ...
Research - Fierce Biotech
WEBSep 11, 2024 · People with Duffy null blood are excluded from cancer clinical trials and given lower drug doses that may be ineffective, a study found. Darren Incorvaia Sep 11, 2024 1:49pm. Connect.
Regeneron to fill gaps in obesity, break ground in cell therapy
WEBFeb 2, 2024 · Regeneron wants to fill the gaps in care with a combo approach from its pipeline, adding trevogrumab or garetosmab to semaglutide (Wegovy) to improve the quality of weight loss that patients ...
FDA will review vibrating constipation pill from Vibrant Gastro
WEBMay 23, 2022 · Among 312 participants, 39% reported at least one additional complete bowel movement per week, compared to 22% of those given a placebo pill. Over 22% logged two or more, versus 11% in the control ...
Clinical Data - Fierce Biotech
WEB4 days ago · Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials. James Waldron Sep 11, 2024 11:45am. Connect.